ADAM17 and ischemic stroke: Protein assays supported these observations, as ischemic stroke patients displayed significantly heightened cellular ADAM17 activity in peripheral blood total hemocyte fractions (Fig. 1C), as well as significantly elevated plasma levels of sCD163 (Fig. 1D), once again in an age-independent fashion.